DNDi and Cipla to Develop 4-in-1 Pediatric Antiretroviral Drug Combination

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

Filed under: Drug Treatment Help Washington D.C.

Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit R&D organization, announced a new collaboration with Indian drug manufacturer Cipla (BSE: 500087) to develop …
Read more on The Pharma Letter

Pfizer and J&J end testing of intravenous bapineuzumab Alzheimer's treatment

Filed under: Drug Treatment Help Washington D.C.

NEW YORK — Pfizer Inc. and Johnson & Johnson said Monday they are ending development of an intravenous formulation of a drug to treat Alzheimer's disease after the treatment failed in two late-stage clinical trials. The companies said bapineuzumab …
Read more on Washington Post